Shanghai Pharmaceuticals Holding Co., Ltd (02607.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

8.1x

EV/EBITDA

8.2x

Market Cap

HKD 42.91B

MomentumView details →

1D Return

+1.49%

YTD Return

+1.67%

RSI (14)

47.8

ValuationView details →

P/E (Fwd)

8.1x

EV/EBITDA

8.2x

Market Cap

HKD 42.91B

RSI (14)

47.8

MomentumView details →

1D Return

+1.49%

YTD Return

+1.67%

ProfitabilityView details →

Gross Margin

10.81%

Net Margin

1.65%

EBITDA Margin

3.01%

ROE (TTM)

6.06%

ROA (TTM)

1.97%

Asset Turnover

1.21x

GrowthView details →

Revenue YoY

+3.97%

EPS YoY

−22.09%

FCF YoY

+302.04%

Revenue CAGR 3Y

+6.92%

EPS CAGR 3Y

−1.47%

EBITDA YoY

−7.32%

EarningsView details →

EPS (Actual)

HKD 0.76

EPS Surprise

0.00%

Beats (12Q)

0/12

Next Q EPS Est

HKD 0.27

Avg Surprise (4Q)

0.00%

Rev Surprise

−4.85%

Capital & dividendView details →

Debt/Equity

0.84x

Current Ratio

1.34x

Quick Ratio

1.04x

Div Yield

4.64%

Div Rate

HKD 0.54

Div Growth 1Y

−9.87%

Financials snapshotView financials →

Revenue (TTM)

288.45B

Net Income (TTM)

4.75B

Op. CF (TTM)

9.91B

Next earningsOct 23, 2026 →

Latest newsMore news →

Shanghai Pharmaceuticals declared an interim dividend of RMB 0.10 per share for the six months ended June 2026, down from RMB 0.12 per share in the prior year.8d ago

Shanghai Pharmaceuticals reported a net profit of 3.50 billion yuan for the first half of 2026.8d ago

Similar companies

Sinopharm Group Co. Ltd.01099.HK Cardinal Health, Inc.CAH 上海医药601607.SH Cencora, Inc.COR 九州通600998.SH 国药股份600511.SH Find similar companies →

Latest newsMore news →

Shanghai Pharmaceuticals declared an interim dividend of RMB 0.10 per share for the six months ended June 2026, down from RMB 0.12 per share in the prior year.8d ago Shanghai Pharmaceuticals reported a net profit of 3.50 billion yuan for the first half of 2026.8d ago Shanghai Pharmaceuticals announced that its wholly-owned subsidiary Shanghai Pharma Holding will publicly list for transfer its 51% stake in subsidiary Shanghai Shangyao Xinte Dong'an Pharmacy Co., Ltd. via a property rights exchange, with a proposed minimum price of 179 million yuan.11d ago